- Joined
- Aug 16, 2005
- Messages
- 110
- Reaction score
- 80
Hi all,
I work in Canada and I wanted to get some of your opinions on the latest (CCS) Canadian Cardiovascular Society Guidelines.
http://www.onlinecjc.ca/article/S0828-282X(16)30980-1/abstract
Compared to the American AHA guidelines, the new recommendation for us is now to forgo most of the invasive/procedural testing and do a BNP in the patient and then to monitor for troponin rise in those that are deemed high risk. Potential cost savings are pretty big. It costs about $20 CDN to run a point of care BNP sample here. The CCS guidelines are also easier to follow than the AHA guidelines.
I was wondering if any of you have started integrating BNP into your practice in the perioperative setting? Thanks.
I work in Canada and I wanted to get some of your opinions on the latest (CCS) Canadian Cardiovascular Society Guidelines.
http://www.onlinecjc.ca/article/S0828-282X(16)30980-1/abstract
Compared to the American AHA guidelines, the new recommendation for us is now to forgo most of the invasive/procedural testing and do a BNP in the patient and then to monitor for troponin rise in those that are deemed high risk. Potential cost savings are pretty big. It costs about $20 CDN to run a point of care BNP sample here. The CCS guidelines are also easier to follow than the AHA guidelines.
I was wondering if any of you have started integrating BNP into your practice in the perioperative setting? Thanks.
Last edited: